Gastrointestinal Manifestations of Eating Disorders
Corresponding Author
Elana M. Bern
Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA
Address correspondence and reprint requests to Elana M. Bern, MD, MPH, Assistant Professor, Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115 (e-mail: [email protected]).Search for more papers by this authorElizabeth R. Woods
Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA
Search for more papers by this authorLeonel Rodriguez
Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA
Search for more papers by this authorCorresponding Author
Elana M. Bern
Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA
Address correspondence and reprint requests to Elana M. Bern, MD, MPH, Assistant Professor, Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115 (e-mail: [email protected]).Search for more papers by this authorElizabeth R. Woods
Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA
Search for more papers by this authorLeonel Rodriguez
Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA
Search for more papers by this authorE.R.W. was supported in part by the Leadership Education in Adolescent Health grant #T71MC00009 Maternal and Child Health Bureau, Health Resources and Services Administration.
The authors report no conflicts of interest.
ABSTRACT
Individuals with eating disorders, including anorexia nervosa and bulimia nervosa, may present with a range of gastrointestinal (GI) manifestations. The oral cavity, salivary glands, GI tract, pancreas, and liver can be impacted by nutritional restrictive and binge/purging behaviors. Complications are often reversible with appropriate nutritional therapy. At times, however, the complications in these disorders may be severe, irreversible and even life threatening. Given the often covert nature of eating disorders, the practitioner must be attentive to subtle clues that may indicate their presence. Extensive diagnostic evaluations of the GI manifestations of eating disorders should be used only when nutritional rehabilitation does not remedy the problems.
REFERENCES
- 1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
10.1176/appi.books.9780890425596 Google Scholar
- 2.Culbert KM, Racine SE, Klump KL. Research review: what we have learned about the causes of eating disorders--a synthesis of sociocultural, psychological, and biological research. J Child Psychol Psychiatry 2015; 56: 1141–1164.
- 3.Johansson AK, Norring C, Unell L, et al. Eating disorders and oral health: a matched case-control study. Eur J Oral Sci 2012; 120: 61–68.
- 4.Romanos GE, Javed F, Romanos EB, et al. Oro-facial manifestations in patients with eating disorders. Appetite 2012; 59: 499–504.
- 5.Lo Russo L, Campisi G, Di Fede O, et al. Oral manifestations of eating disorders: a critical review. Oral Dis 2008; 14: 479–484.
- 6.Imfeld T Dental erosion Definition, classification and links. Eur J Oral Sci 1996; 104 (2 pt 2): 151–155.
- 7.McIntyre JM. Erosion. Aust Prosthodont J 1992; 6: 17–25.
- 8.Mehler PS. Medical complications of bulimia nervosa and their treatments. Int J Eat Disord 2011; 44: 95–104.
- 9.Preetha A, Sujatha D, Patil BA, et al. Oral manifestations in gastroesophageal reflux disease. Gen Dent 2015; 63: e27–e31.
- 10.Mueller JA. Eating disorders: identification and intervention. J Contemp Dent Pract 2001; 2: 98.
- 11.Sedghizadeh PP. Images in clinical medicine. Bulimia nervosa. N Engl J Med 2013; 368: 1238.
- 12.Christopher K, Tammaro D, Wing EJ. Early scurvy complicating anorexia nervosa. South Med J 2002; 95: 1065–1066.
- 13.Flores IL, Santos-Silva AR, Coletta RD, et al. Widespread red oral lesions. J Am Dent Assoc 2013; 144: 1257–1260.
- 14.Lu SY, Wu HC. Initial diagnosis of anemia from sore mouth and improved classification of anemias by MCV and RDW in 30 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 679–685.
- 15.Paillaud E, Merlier I, Dupeyron C, et al. Oral candidiasis and nutritional deficiencies in elderly hospitalised patients. Br J Nutr 2004; 92: 861–867.
- 16.Mandel L. Salivary gland disorders. Med Clin North Am 2014; 98: 1407–1449.
- 17.Donath K, Seifert G. Ultrastructural studies of the parotid glands in sialadenosis. Virchows Arch A Pathol Anat Histol 1975; 365: 119–135.
- 18.Coleman H, Altini M, Nayler S, et al. Sialadenosis: a presenting sign in bulimia. Head Neck 1998; 20: 758–762.
10.1002/(SICI)1097-0347(199812)20:8<758::AID-HED16>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- 19.Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 2004; 15: 221–239.
- 20.Riad M, Barton JR, Wilson JA, et al. Parotid salivary secretory pattern in bulimia nervosa. Acta Otolaryngol 1991; 111: 392–395.
- 21.Solomon LW, Merzianu M, Sullivan M, et al. Necrotizing sialometaplasia associated with bulimia: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: e39–42.
- 22.Kaplan I, Alterman M, Kleinman S, et al. The clinical, histologic, and treatment spectrum in necrotizing sialometaplasia. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 577–585.
- 23.Gilowski L, Wiench R, Polakiewicz-Gilowska A, et al. Necrotizing sialometaplasia of the palatal mucosa in patient with history of anorexia: review and case report. Am J Otolaryngol 2014; 35: 400–401.
- 24.Gryboski JD. Eating disorders in inflammatory bowel disease. Am J Gastroenterol 1993; 88: 293–296.
- 25.Reas DL, Zipfel S, Ro O. Is it an eating disorder or achalasia or both? A literature review and diagnostic challenges. Eur Eat Disord Rev 2014; 22: 321–330.
- 26.Leffler DA, Dennis M, Edwards George JB, et al. The interaction between eating disorders and celiac disease: an exploration of 10 cases. Eur J Gastroenterol Hepatol 2007; 19: 251–255.
- 27.Jenkins AP, Treasure J, Thompson RP. Crohn's disease presenting as anorexia nervosa. Br Med J (Clin Res Ed) 1988; 296: 699–700.
- 28.Bern EM, O’Brien RF. Is it an eating disorder, gastrointestinal disorder, or both? Curr Opin Pediatr 2013; 25: 463–470.
- 29.Wang X, Luscombe GM, Boyd C, et al. Functional gastrointestinal disorders in eating disorder patients: altered distribution and predictors using ROME III compared to ROME II criteria. World J Gastroenterol 2014; 20: 16293–16299.
- 30.Oberne A, DeBate R. Self-induced vomiting as a function of bulimia nervosa increases the risk for oral health issues. J Evid Based Dent Pract 2014; 14: 195–196.
- 31.Pettersen G, Rosenvinge JH, Ytterhus B. The “double life” of bulimia: patients’ experiences in daily life interactions. Eat Disord 2008; 16: 204–211.
- 32.Kiss A, Bergmann H, Abatzi TA, et al. Oesophageal and gastric motor activity in patients with bulimia nervosa. Gut 1990; 31: 259–265.
- 33.Denholm M, Jankowski J. Gastroesophageal reflux disease and bulimia nervosa--a review of the literature. Dis Esophagus 2011; 24: 79–85.
- 34.Rothstein SG. Reflux and vocal disorders in singers with bulimia. J Voice 1998; 12: 89–90.
- 35.Kiss A, Wiesnagrotzki S, Abatzi TA, et al. Upper gastrointestinal endoscopy findings in patients with long-standing bulimia nervosa. Gastrointest Endosc 1989; 35: 516–518.
- 36.Shinohara ET, Swisher-McClure S, Husson M, et al. Esophageal cancer in a young woman with bulimia nervosa: a case report. J Med Case Rep 2007; 1: 160.
- 37.Nickl NJ, Brazer SR, Rockwell K, et al. Patterns of esophageal motility in patients with stable bulimia. Am J Gastroenterol 1996; 91: 2544–2547.
- 38.Benini L, Todesco T, Frulloni L, et al. Esophageal motility and symptoms in restricting and binge-eating/purging anorexia. Dig Liver Dis 2010; 42: 767–772.
- 39.Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15: 237–241.
- 40.Holmes SR, Gudridge TA, Gaudiani JL, et al. Dysphagia in severe anorexia nervosa and potential therapeutic intervention: a case series. Ann Otol Rhinol Laryngol 2012; 121: 449–456.
- 41.Overby KJ, Litt IF. Mediastinal emphysema in an adolescent with anorexia nervosa and self-induced emesis. Pediatrics 1988; 81: 134–136.
- 42.Hadley SJ, Walsh BT. Gastrointestinal disturbances in anorexia nervosa and bulimia nervosa. Curr Drug Targets CNS Neurol Disord 2003; 2: 1–9.
- 43.Rigaud D, Bedig G, Merrouche M, et al. Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci 1988; 33: 919–925.
- 44.Holt S, Ford MJ, Grant S, et al. Abnormal gastric emptying in primary anorexia nervosa. Br J Psychiatry 1981; 139: 550–552.
- 45.McCallum RW, Grill BB, Lange R, et al. Definition of a gastric emptying abnormality in patients with anorexia nervosa. Dig Dis Sci 1985; 30: 713–722.
- 46.Abell TL, Malagelada JR, Lucas AR, et al. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology 1987; 93: 958–965.
- 47.Hutson WR, Wald A. Gastric emptying in patients with bulimia nervosa and anorexia nervosa. Am J Gastroenterol 1990; 85: 41–46.
- 48.Robinson PH, Clarke M, Barrett J. Determinants of delayed gastric emptying in anorexia nervosa and bulimia nervosa. Gut 1988; 29: 458–464.
- 49.Diamanti A, Bracci F, Gambarara M, et al. Gastric electric activity assessed by electrogastrography and gastric emptying scintigraphy in adolescents with eating disorders. J Pediatr Gastroenterol Nutr 2003; 37: 35–41.
- 50.Perez ME, Coley B, Crandall W, et al. Effect of nutritional rehabilitation on gastric motility and somatization in adolescents with anorexia. J Pediatr 2013; 163: 867.e1–872.e1.
- 51.Geracioti TD Jr, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988; 319: 683–688.
- 52.Geliebter A, Hashim SA. Gastric capacity in normal, obese, and bulimic women. Physiol Behav 2001; 74: 743–746.
- 53.Devlin MJ, Walsh BT, Guss JL, et al. Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr 1997; 65: 114–120.
- 54.Benini L, Todesco T, Dalle Grave R, et al. Gastric emptying in patients with restricting and binge/purging subtypes of anorexia nervosa. Am J Gastroenterol 2004; 99: 1448–1454.
- 55.Dubois A, Gross HA, Richter JE, et al. Effect of bethanechol on gastric functions in primary anorexia nervosa. Dig Dis Sci 1981; 26: 598–600.
- 56.Szmukler GI, Young GP, Lichtenstein M, et al. A serial study of gastric emptying in anorexia nervosa and bulimia. Aust N Z J Med 1990; 20: 220–225.
- 57.Stacher G, Abatzi-Wenzel TA, Wiesnagrotzki S, et al. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. Br J Psychiatry 1993; 162: 398–402.
- 58.Stacher G, Peeters TL, Bergmann H, et al. Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa. Gut 1993; 34: 166–172.
- 59.Russell DM, Freedman ML, Feiglin DH, et al. Delayed gastric emptying and improvement with domperidone in a patient with anorexia nervosa. Am J Psychiatry 1983; 140: 1235–1236.
- 60.Saleh JW, Lebwohl P. Metoclopramide-induced gastric emptying in patients with anorexia nervosa. Am J Gastroenterol 1980; 74: 127–132.
- 61.Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108: 18–37.
- 62.Rodriguez L, Diaz J, Nurko S. Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children. J Pediatr 2013; 163: 261–267.
- 63.Halmi KA, Eckert E, LaDu TJ, et al. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986; 43: 177–181.
- 64.Tjeerdsma HC, Smout AJ, Akkermans LM. Voluntary suppression of defecation delays gastric emptying. Dig Dis Sci 1993; 38: 832–836.
- 65.Birmingham CL, Cardew S, Gritzner S. Gastric bezoar in anorexia nervosa. Eat Weight Disord 2007; 12: e28–e29.
- 66.Norris ML, Harrison ME, Isserlin L, et al. Gastrointestinal complications associated with anorexia nervosa: a systematic review. Int J Eat Disord 2016; 49: 216–237.
- 67.Mascolo M, Dee E, Townsend R, et al. Severe gastric dilatation due to superior mesenteric artery syndrome in anorexia nervosa. Int J Eat Disord 2015; 48: 532–534.
- 68.Edlich RF, Borner JW, Kuphal J, et al. Gastric blood flow. I. Its distribution during gastric distention. Am J Surg 1970; 120: 35–37.
- 69.Abdu RA, Garritano D, Culver O. Acute gastric necrosis in anorexia nervosa and bulimia. Two case reports. Arch Surg 1987; 122: 830–832.
- 70.Jennings KP, Klidjian AM. Acute gastric dilatation in anorexia nervosa. Br Med J 1974; 2: 477–478.
- 71.Van Eetvelde E, Verfaillie L, Van De Winkel N, et al. Acute gastric dilatation causing acute limb ischemia in an anorexia nervosa patient. J Emerg Med 2014; 46: e141–e143.
- 72.Hirakawa M, Okada T, Iida M, et al. Small bowel transit time measured by hydrogen breath test in patients with anorexia nervosa. Dig Dis Sci 1990; 35: 733–736.
- 73.Kamal N, Chami T, Andersen A, et al. Delayed gastrointestinal transit times in anorexia nervosa and bulimia nervosa. Gastroenterology 1991; 101: 1320–1324.
- 74.Ferraris RP, Carey HV. Intestinal transport during fasting and malnutrition. Annu Rev Nutr 2000; 20: 195–219.
- 75.Chappell VL, Thompson MD, Jeschke MG, et al. Effects of incremental starvation on gut mucosa. Dig Dis Sci 2003; 48: 765–769.
- 76.Winter TA, Lemmer ER, O’Keefe SJ, et al. The effect of severe undernutrition, and subsequent refeeding on digestive function in human patients. Eur J Gastroenterol Hepatol 2000; 12: 191–196.
- 77.Welsh FK, Farmery SM, MacLennan K, et al. Gut barrier function in malnourished patients. Gut 1998; 42: 396–401.
- 78.Monteleone P, Carratu R, Carteni M, et al. Intestinal permeability is decreased in anorexia nervosa. Mol Psychiatry 2004; 9: 76–80.
- 79.Juby LD, Rothwell J, Axon AT. Lactulose/mannitol test: an ideal screen for celiac disease. Gastroenterology 1989; 96: 79–85.
- 80.Martinez-Olmos MA, Peino R, Prieto-Tenreiro A, et al. Intestinal absorption and pancreatic function are preserved in anorexia nervosa patients in both a severely malnourished state and after recovery. Eur Eat Disord Rev 2013; 21: 247–251.
- 81.Craig RM, Atkinson AJ Jr. D-Xylose testing: a review. Gastroenterol 1988; 95: 223–231.
- 82.Watkins JB, Klein PD, Schoeller DA, et al. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology 1982; 82 (5 Pt 1): 911–917.
- 83.Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, et al. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 484–488.
- 84.Rabie ME, Ogunbiyi O, Al Qahtani AS, et al. Superior mesenteric artery syndrome: clinical and radiological considerations. Surg Res Pract 2015; 2015: 628705.
- 85.Bowden DJ, Kilburn-Toppin F, Scoffings DJ. Radiology of eating disorders: a pictorial review. Radiographics 2013; 33: 1171–1193.
- 86.Unal B, Aktas A, Kemal G, et al. Superior mesenteric artery syndrome: CT and ultrasonography findings. Diagn Interv Radiol 2005; 11: 90–95.
- 87.Merrett ND, Wilson RB, Cosman P, et al. Superior mesenteric artery syndrome: diagnosis and treatment strategies. J Gastrointest Surg 2009; 13: 287–292.
- 88.Adson DE, Mitchell JE, Trenkner SW. The superior mesenteric artery syndrome and acute gastric dilatation in eating disorders: a report of two cases and a review of the literature. Int J Eat Disord 1997; 21: 103–114.
10.1002/(SICI)1098-108X(199703)21:2<103::AID-EAT1>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- 89.Stoving RK, Hangaard J, Hansen-Nord M, et al. A review of endocrine changes in anorexia nervosa. J Psychiatr Res 1999; 33: 139–152.
- 90.Crow SJ, Salisbury JJ, Crosby RD, et al. Serum electrolytes as markers of vomiting in bulimia nervosa. Int J Eat Disord 1997; 21: 95–98.
10.1002/(SICI)1098-108X(199701)21:1<95::AID-EAT12>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- 91.Gorard DA, Libby GW, Farthing MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 159–166.
- 92.Bo-Linn GW, Santa Ana CA, Morawski SG, et al. Purging and calorie absorption in bulimic patients and normal women. Ann Intern Med 1983; 99: 14–17.
- 93.Roerig JL, Steffen KJ, Mitchell JE, et al. Laxative abuse: epidemiology, diagnosis and management. Drugs 2010; 70: 1487–1503.
- 94.Chun AB, Sokol MS, Kaye WH, et al. Colonic and anorectal function in constipated patients with anorexia nervosa. Am J Gastroenterol 1997; 92: 1879–1883.
- 95.Chiarioni G, Bassotti G, Monsignori A, et al. Anorectal dysfunction in constipated women with anorexia nervosa. Mayo Clin Proc 2000; 75: 1015–1019.
- 96.Kovacs D, Palmer RL. The associations between laxative abuse and other symptoms among adults with anorexia nervosa. Int J Eat Disord 2004; 36: 224–228.
- 97.Steffen KJ, Mitchell JE, Roerig JL, et al. The eating disorders medicine cabinet revisited: a clinician's guide to ipecac and laxatives. Int J Eat Disord 2007; 40: 360–368.
- 98.Turner J, Batik M, Palmer LJ, et al. Detection and importance of laxative use in adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2000; 39: 378–385.
- 99.Slung PH, Carey WD. Clinical features and follow-up of surreptitious laxative users. Cleve Clin Q 1984; 51: 167–171.
- 100.Qureshi T, Melonakos TK. Acute hypermagnesemia after laxative use. Ann Emerg Med 1996; 28: 552–555.
- 101.He CL, Burgart L, Wang L, et al. Decreased interstitial cell of cajal volume in patients with slow-transit constipation. Gastroenterology 2000; 118: 14–21.
- 102.Wedel T, Spiegler J, Soellner S, et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 2002; 123: 1459–1467.
- 103.Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol 2003; 36: 386–389.
- 104.Ewe K. The physiological basis of laxative action. Pharmacology 1980; 20 (suppl 1): 2–20.
- 105.De Ponti F, De Giorgio R. The cathartic colon? Aliment Pharmacol Ther 2002; 16: 643–644.
- 106.Fioramonti J, Bueno L. Toxicity of laxatives: how to discriminate between myth and fact? Eur J Gastroenterol Hepatol 1995; 7: 5–7.
- 107.Muller-Lissner S. What has happened to the cathartic colon? Gut 1996; 39: 486–488.
- 108.Krishnamurthy S, Schuffler MD, Rohrmann CA, et al. Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 1985; 88 (1 pt 1): 26–34.
- 109.De Giorgio R, Stanghellini V, Barbara G, et al. Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol 2000; 35: 114–122.
- 110.Dunnick JK, Hailey JR. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res 1996; 56: 4922–4926.
- 111.Coogan PF, Rosenberg L, Palmer JR, et al. Phenolphthalein laxatives and risk of cancer. J Natl Cancer Inst 2000; 92: 1943–1944.
- 112.Gaginella TS, Haddad AC, Go VL, et al. Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. J Pharmacol Exp Ther 1977; 201: 259–266.
- 113.Mitty RD, Wolfe GR, Cosman M. Initial description of gastric melanosis in a laxative-abusing patient. Am J Gastroenterol 1997; 92: 707–708.
- 114.van Gorkom BA, de Vries EG, Karrenbeld A, et al. Review article: anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther 1999; 13: 443–452.
- 115.Siegers CP. Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci 1992; 13: 229–231.
- 116.Nusko G, Schneider B, Schneider I, et al. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case-control study. Gut 2000; 46: 651–655.
- 117.Diamanti A, Basso MS, Cecchetti C, et al. Digestive complication in severe malnourished anorexia nervosa patient: a case report of necrotizing colitis. Int J Eat Disord 2011; 44: 91–93.
- 118.Shaper AG. Chronic pancreatic disease and protein malnutrition. Lancet 1960; 1: 1223–1224.
- 119.Pitchumoni CS. Pancreas in primary malnutrition disorders. Am J Clin Nutr 1973; 26: 374–379.
- 120.Barbezat GO, Hansen JD. The exocrine pancreas and protein-calorie malnutrition. Pediatrics 1968; 42: 77–92.
- 121.Naruse S, Ishiguro H, Ko SB, et al. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. J Gastroenterol 2006; 41: 901–908.
- 122.Dominici R, Franzini C. Fecal elastase-1 as a test for pancreatic function: a review. Clin Chem Lab Med 2002; 40: 325–332.
- 123.Dominguez-Munoz JE, Hieronymus C, Sauerbruch T, et al. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995; 90: 1834–1837.
- 124.Keane FB, Fennell JS, Tomkin GH. Acute pancreatitis, acute gastric dilation and duodenal ileus following refeeding in anorexia nervosa. Ir J Med Sci 1978; 147: 191–192.
- 125.Muniraj T, Dang S, Pitchumoni CS. Pancreatitis or not? Elevated lipase and amylase in ICU patients. J Crit Care 2015; 30: 1370–1375.
- 126.Lelli L, Castellini G, Gabbani T, et al. Associations between liver enzymes, psychopathological and clinical features in eating disorders. Eur Eat Disord Rev 2014; 22: 443–447.
- 127.Mickley D, Greenfeld D, Quinlan DM, et al. Abnormal liver enzymes in outpatients with eating disorders. Int J Eat Disord 1996; 20: 325–329.
10.1002/(SICI)1098-108X(199611)20:3<325::AID-EAT13>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- 128.Tomita K, Haga H, Ishii G, et al. Clinical manifestations of liver injury in patients with anorexia nervosa. Hepatol Res 2014; 44: E26–31.
- 129.Nagata JM, Park KT, Colditz K, et al. Associations of elevated liver enzymes among hospitalized adolescents with anorexia nervosa. J Pediatr 2015; 166: 439.e1–443.e1.
- 130.Kheloufi M, Boulanger CM, Durand F, et al. Liver autophagy in anorexia nervosa and acute liver injury. Biomed Res Int 2014; 2014: 701064.
- 131.Rautou PE, Mansouri A, Lebrec D, et al. Autophagy in liver diseases. J Hepatol 2010; 53: 1123–1134.
- 132.Rautou PE, Cazals-Hatem D, Moreau R, et al. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology 2008; 135: 840–848.48.e1-3.
- 133.Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009; 35: 1397–1405.